Davis R M Inc Regeneron Pharmaceuticals, Inc. Transaction History

Davis R M Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $9,216 - $10,815	-9 Reduced 3.1%	281 $295,000
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $6,182 - $7,498	-7 Reduced 2.36%	290 $304,000
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $6,318 - $6,953	7 Added 2.41%	297 $285,000
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $31,501 - $37,365	45 Added 18.37%	290 $208,000
Q1 2023 May 01, 2023	BUY	$680.49 - $826.97 $166,720 - $202,607	245 New	245 $201,000

1,487

84.6M

1.29M

1.47M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $71.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

Stay updated on Davis R M Inc with notifications on news.